2021 Emerging Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers

March 2021 | 145 pages | ID: 24F5C09BEFEEN
Venture Planning Group

Abstracts

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.

The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 145 pages

Contents

Current and Emerging Technologies
Monoclonal and Polyclonal Antibodies
Immunoassays
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
IT and Automation
Dry Chemistry
Biosensors
Robotics
Molecular Diagnostics
    a. Detection Technologies
  1. Radioactive Methods
  2. Non-Isotopic Methods
    b. Instrumentation Review
Abbott LCX
BeckmanCoulter/Biomek FX
Becton Dickinson
Bio-Rad Gene Scope
Table of Contents (Continued)
Roche Cobas Amplicor
  Tecan LS Series
    c. Biochips Genosensor, Microarrays, Labs-on-the-Chips
Chemometrics

COMPETITIVE PROFILES

Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio Grifols
Instrumentation
Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako